CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $261,000 | +16.0% | 112,157 | +41.3% | 0.01% | 0.0% |
| Q4 2017 | $225,000 | -7.4% | 79,357 | -6.7% | 0.01% | -16.7% |
| Q3 2017 | $243,000 | -37.2% | 85,079 | -20.8% | 0.01% | -33.3% |
| Q1 2017 | $387,000 | -32.9% | 107,400 | -34.2% | 0.02% | -47.1% |
| Q4 2016 | $577,000 | +815.9% | 163,100 | +938.9% | 0.03% | +70.0% |
| Q3 2016 | $63,000 | -97.0% | 15,700 | -96.8% | 0.02% | -81.1% |
| Q2 2016 | $2,123,000 | -38.4% | 483,807 | -46.9% | 0.11% | -31.2% |
| Q1 2016 | $3,446,000 | +1283.9% | 911,825 | +10090.3% | 0.15% | +1611.1% |
| Q1 2015 | $249,000 | -83.6% | 8,948 | -89.6% | 0.01% | -88.8% |
| Q1 2014 | $1,518,000 | +94.6% | 85,939 | +166.6% | 0.08% | +95.1% |
| Q4 2013 | $780,000 | -17.9% | 32,231 | -47.1% | 0.04% | +32.3% |
| Q2 2013 | $950,000 | – | 60,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |